Module 1 Webcast (2018): Core Urology - Exam Overview and Test Taking Logistics

Specifically designed for anyone unable to get away from the office to attend the Live Course, the Webcast option delivers the same great content. Purchase of the Webcast features simultaneous presentation slides and audio recorded from the Live Course and includes access to online course materials.

The purpose of the Life Long Learning Prep Course: A Focused Review is to prepare attendees for the ABU knowledge assessment. This course will be practice-focused and will offer practical and clinically-specific updates. It will highlight the AUA guidelines and address general urology practice issues that can be expected on the knowledge assessment. The course will model the changes to the ABU exam by covering Core/General Urology on the first day followed by Module 1: Oncology, Urinary Diversion and Adrenal on the second day.

Sample multiple choice practice questions as well as case-based discussions and debates will be utilized to prepare attendees for the upcoming knowledge assessment. For more information on the changes to the exam, please visit www.abu.org/recertification.

 

Target Audience

  • Urologists

Learning Objectives

CORE UROLOGY

At the conclusion of this activity, participants will be able to:

  1. Review generally accepted urological practices for superior patient care.
  2. Discuss a core knowledge of urology necessary for taking the Knowledge Assessment.
  3. Examine the most recent changes and additions to the AUA guidelines.

MODULE 1: ONCOLOGY & URINARY DIVERSION

At the conclusion of this activity, participants will be able to:

  1. Discuss the appropriate indications for and use diagnostic tests in the management of urologic cancers.
  2. Enhance ability to make guideline-based decisions regarding management of common urologic cancers.
  3. Recognize and execute appropriate measures to prevent and manage complications resulting for management intervention for urologic cancers.
  4. Develop and employ a disease stage appropriate surveillance schedule during post management follow-up of urologic cancers.
Course summary

CORE UROLOGY

Exam Overview and Test Taking Logistics: Gerald H. Jordan, MD                                  
General Cancer 1 (Localized/Advanced Prostate, Localized Kidney): Mark L. Gonzalgo, MD, PhD
General Cancer 2 (Bladder, Upper Tract TCC, Advanced Kidney): Siamak Daneshmand, MD
Medical Urology: Hypertension, Fluids and Electrolytes, Nephrology: Sarah Elfering, MD
Trauma: Jay Simhan, MD
Geriatric Urology: Deborah J. Lightner, MD
Complications of Urologic Surgery: Jay D. Raman, MD
Endocrine: Daniel H. Williams, IV, MD & Sarah Elfering
Stones (not metabolic stones): Mantu Gupta, MD
Prostate Evaluation/Biopsy: Jay D. Raman, MD
Infection: Robert J. Evans, MD, FACS
Radiology/ Radiation Safety: Timothy D. Averch, MD
Office Based Practice and Guidelines: Deborah J. Lightner, MD

MODULE 1: ONCOLOGY, URINARY DIVERSION AND ADRENAL

Upper Tract Tumors/ Urinary Diversion: Christopher J. Weight, MD
Prostate Cancer – Localized: Mark L. Gonzalgo, MD, PhD
Testicular Cancer:  Christopher J. Weight, MD
Penile/Urethral Cancer: Siamak Daneshmand, MD
Urothelial Bladder Cancer: Siamak Daneshmand, MD
Adrenal: Mohamad E. Allaf, MD
Kidney Cancer: Mohamad E. Allaf, MD
Prostate Cancer – Advanced: Mark L. Gonzalgo, MD, PhD
Mock Multiple Choice Exam and Review: All Faculty

COURSE DIRECTOR

Timothy Averch, MD, FACS: Bard Urologic: Consultant or Advisor, Meeting Participant or Lecturer; Cook Urological, Inc: Consultant or Advisor; Canadian Journal of Urology: Health Publishing; Journal of Endourology: Health Publishing; Journal of Urology: Health Publishing
Daniel H. Williams, IV, MD: Nothing to disclose

FACULTY

Mohamad E. Allaf, MD: Nothing to disclose             
Nelson E. Bennett Jr., MD: Coloplast: Meeting Participant or Lecturer; AMS: Meeting Participant or Lecturer, Scientific Study or Trial; Boston Scientific: Consultant or Advisor; Endo: Meeting Participant or Lecturer; Coloplast: Consultant or Advisor
Sam B. Bhayani, MD: Intuitive Surgical: Meeting Participant or Lecturer; conmed: Consultant or Advisor, Investment Interest; intuitive: Consultant or Advisor , Consultant or Advisor
Benjamin M. Brucker, MD: Allergan: Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial; Sophiris bio inc.: Scientific Study or Trial; Cook myosite: Scientific Study or Trial; Covance: Scientific Study or Trial; Conti Watson : Consultant or Advisor; Avadel: Consultant or Advisor; Serenity: Consultant or Advisor
Christopher J. Chermansky, MD: Astellas: Consultant or Advisor, Meeting Participant or Lecturer; Contura: Scientific Study or Trial; Allergan: Meeting Participant or Lecturer; Cook Myosite: Scientific Study or Trial; Coulter Foundation Grant through Univ of Pitt School of Engineering: Scientific Study or Trial; Allergan: Scientific Study or Trial , Scientific Study or Trial
Siamak Daneshmand, MD: Endo: Meeting Participant or Lecturer; Cubist: Meeting Participant or Lecturer; Photocure: Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial; Taris: Consultant or Advisor; Pacific Edge: Consultant or Advisor     
Sarah Elfering, MD: Nothing to disclose
Robert J. Evans, MD, FACS: Interstitial Cystitis Association: Leadership Position; allergan: Scientific Study or Trial; Afferent: Meeting Participant or Lecturer; urigen: Investment Interest; allergan: Scientific Study or Trial; TARIS: Scientific Study or Trial; Astellas: Meeting Participant or Lecturer; afferent: Scientific Study or Trial; medtronic: Meeting Participant or Lecturer; GTX: Consultant or Advisor; aquinox: Consultant or Advisor, Scientific Study or Trial
Mark L. Gonzalgo, MD, PhD: Nothing to disclose
Mantu Gupta, MD: Cook Urological: Meeting Participant or Lecturer; Boston Scientific: Meeting Participant or Lecturer; Olympus: Consultant or Advisor, Meeting Participant or Lecturer, Scientific Study or Trial
Stephen V. Jackman, MD: Nothing to disclose
Deborah J. Lightner, MD: AUA: Health Publishing; Urology/Elsevier: Health Publishing; Neurourology-urodynamics: Health Publishing
Jay D. Raman, MD: American Kidney Stone Management: Investment Interest; MDx Health: Scientific Study or Trial; Urogen Pharma: Consultant or Advisor, Scientific Study or Trial
David Shin, MD: Boston Scientific: Meeting Participant or Lecturer; Vivus: Scientific Study or Trial; Endo Pharmaceuticals: Meeting Participant or Lecturer; Society for the Study of Male Reproduction: Leadership Position; Antares Pharm: Consultant or Advisor
Jay Simhan, MD: Boston Scientific : Meeting Participant or Lecturer; Coloplast: Meeting Participant or Lecturer
John T. Stoffel, MD: Uroplasty: Scientific Study or Trial; PCORI: Scientific Study or Trial; Journal of urology: Leadership Position; Department of Defense: Scientific Study or Trial; Ipsen: Scientific Study or Trial
Christopher J. Weight, MD: Precision Health Economics: Scientific Study or Trial; Myriad Genetics: Scientific Study or Trial; Urogen: Scientific Study or Trial; Abbott Molecular: Meeting Participant or Lecturer

PDF iconEDUCATION COUNCIL DISCLOSURES

Note: This video is a non-CME resource. CME will not be awarded for completion of this video.  

Please login or register to take this course.